
Cervical Cancer Series | HPV & Cervical Cancer
Join us for the second session of LPCA’s Cervical Cancer Prevention Learning Series. This session will build foundational knowledge about HPV and its critical role in cervical cancer development.
Participants will gain a clear understanding of HPV virology, the differences between high-risk and low-risk HPV types, and evidence-based strategies for HPV vaccination, including schedules, recommended age groups, and approaches to improve uptake.
Topics to be covered include:
- HPV virology and its progression to cervical cancer
- High-risk vs. low-risk HPV types
- HPV vaccine: schedules, age groups, and uptake strategies
- Myths and misconceptions about HPV
- Effective communication of HPV risks and prevention strategies to patients
By the end of this session, participants will have the knowledge and tools to confidently educate patients about HPV, address common misconceptions, and implement strategies to improve vaccination rates in their communities.
This webinar will provide an overview of HPV virology and its progression to cervical cancer. Dr. Jernigan will discuss the difference between high-risk and low-risk HPV types and provide information on the HPV vaccine including uptake strategies.
Upcoming Series Sessions:
- Session 3: Cervical Cancer Screening Guidelines, Best Practices, & Strategies to Improve Screening Rates – April 23
- Session 4: HPV Testing – Opportunities and Implementation – May 28
- Session 5: Reducing Variations in Access & Increasing Inclusive Participation in Cervical Cancer Care – June 25
- Session 6: Data, Quality Measures, & Reporting – July 23
- Session 7: Sustaining Gains & Scaling Success – August 20

|
|

Amelia M. Jernigan, MD